journalist reported "there's not much scientific support for its use as an athletic enhancer". Don Catlin, a long-time anti-doping expert and the scientific director of the Banned Substances Control Group (BSCG) said "There's really no evidence that there's any performance enhancement from meldonium – Zero percent". Approval status Meldonium, which is not approved by the FDA in the United States, is registered and prescribed in Latvia, Russia, Ukraine, Georgia, Kazakhstan, Azerbaijan, Belarus, Uzbekistan, Moldova, Lithuania, Albania, and Kyrgyzstan. Economics Meldonium is manufactured by Grindeks, a Latvian pharmaceutical company, with offices in thirteen Eastern European countries as a treatment for heart conditions. The company identifies it as one of their main products. It had sales of 65 million euros in 2013. References Antianginals Doping in sport Drugs acting on the cardiovascular system Drugs in the Soviet Union Hydrazines Ischemic heart diseases Latvian inventions Quaternary ammonium compounds Soviet inventions Zwitterions World Anti-Doping Agency prohibited substances Doping in Russia Drugs in sport